Isis Pharmaceuticals, Inc. (Nasdaq: ISIS) announced that Isis' collaborators presented new clinical data on drugs in Isis' partnered oncology franchise ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE